---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-047278"
form_type: "8-K"
ticker: "CHRN"
cik: "0001549084"
company_name: "EKSO BIONICS HOLDINGS, INC."
filed_at: "2026-10-15T21:08:27+00:00"
generated_at: "2026-10-15T21:10:05.724644+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# ChronoScale Q1 revenue $41.5M, up 148% YoY; net loss widens to $26.4M

## Summary
- Revenue $41.5M vs $16.7M a year ago (+148%), driven by AI infrastructure hardware resale to a new customer; cost of revenues $45.6M, up 91% YoY.
- Net loss from continuing operations $26.4M ($0.18 basic/diluted) vs $11.2M ($0.08) prior year; Adjusted EBITDA $5.9M vs $9.4M.
- Secured 50 MW AI compute deployment with Microsoft in North America using NVIDIA GB300 NVL72 systems; also Nutanix partnership and 3-year Baseten Labs deal (~4 MW, completion calendar Q1 2027).
- Sold Legacy Ekso Business on Sept 30, 2026; discontinued-operations net loss $16.1M; cash and equivalents $15.2M as of Aug 31, 2026.
- Received $328.2M in aggregate customer prepayments; contract extension plus new customer agreement puts company on track for $1B annualized run-rate revenue by calendar Q3 2027.

## SEC filing metadata
- accession: 0001493152-26-047278
- form_type: 8-K
- ticker: CHRN
- cik: 0001549084
- company_name: EKSO BIONICS HOLDINGS, INC.
- filed_at: 2026-10-15T21:08:27+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1549084/000149315226047278/0001493152-26-047278-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1549084/000149315226047278/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-047278
- JSON: https://secwatch.observer/filing/0001493152-26-047278.json
- Plain text: https://secwatch.observer/filing/0001493152-26-047278.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.